Evidence map›Paper›PMID 37112092›Full record

ArticlePolymers2023

Establishing a Framework for Fused Filament Fabrication Process Optimization: A Case Study with PLA Filaments.

Jack Grubbs, Bryer C Sousa, Danielle L Cote

Abstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 3D printing and prostheses: The current state-of-the-art and future directions.Journal of rehabilitation and assistive technologies engineering
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jack GrubbsDepartment of Mechanical and Materials Engineering, Worcester Polytechnic Institute, Worcester, MA 01609, USA.ORCID 0000-0002-4035-4415
Bryer C SousaDepartment of Mechanical and Materials Engineering, Worcester Polytechnic Institute, Worcester, MA 01609, USA.ORCID 0000-0003-1852-8244
Danielle L CoteDepartment of Mechanical and Materials Engineering, Worcester Polytechnic Institute, Worcester, MA 01609, USA.ORCID 0000-0002-3571-1721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developments in polymer 3D printing (3DP) technologies have expanded their scope beyond the rapid prototyping space into other high-value markets, including the consumer sector. Processes such as fused filament fabrication (FFF) are capable of quickly producing complex, low-cost components using a wide variety of material types, such as polylactic acid (PLA). However, FFF has seen limited scalability in functional part production partly due to the difficulty of process optimization with its complex parameter space, including material type, filament characteristics, printer conditions, and "slicer" software settings. Therefore, the aim of this study is to establish a multi-step process optimization methodology-from printer calibration to "slicer" setting adjustments to post-processing-to make FFF more accessible across material types, using PLA as a case study. The results showed filament-specific deviations in optimal print conditions, where part dimensions and tensile properties varied depending on the combination of nozzle temperature, print bed conditions, infill settings, and annealing condition. By implementing the filament-specific optimization framework established in this study beyond the scope of PLA, more efficient processing of new materials will be possible for enhanced applicability of FFF in the 3DP field.

Indexed as

additive manufacturingdimensional accuracyFFFmechanical propertiesoptimizationPLA

Identifiers

PMID37112092
PMCPMC10141671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.